Stock Screener App

Gratuito -

Installare

1.33

2.31% 0.03

Acrivon Therapeutics Inc (ACRV)

Panoramica Notizia Cronologia dei prezzi Financials Forum Previsione

Acrivon Therapeutics Inc Azioni (ACRV) Dati Finanziari

*Tutti i numeri sono espressi in milioni

Data di fine periodo	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31
Durata del periodo	3 mesi	3 mesi	3 mesi	3 mesi	3 mesi
Revenues	-	-	-	-	-
Operating Expenses	13.19% 21.66	24.95	25.14	21.44	17.67
Operating Income/Loss	13.19% -21.66	-24.95	-25.14	-21.44	-17.67
Nonoperating Income/Loss	6.64% 1.982	2.123	2.699	2.639	1.182
Income/Loss From Continuing Operations Before Tax	13.80% -19.68	-22.83	-22.44	-18.80	-16.49
Income/Loss From Continuing Operations After Tax	13.80% -19.68	-22.83	-22.44	-18.80	-16.49
Net Income/Loss	13.80% -19.68	-22.83	-22.44	-18.80	-16.49
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	2,466% 38.35	1.4944	38.11	36.13	22.59
Diluted Average Shares	2,466% 38.35	1.4944	38.11	36.13	22.59
Basic Earnings Per Share	13.56% -0.51	-0.59	-0.59	-0.52	-0.73
Diluted Earnings Per Share	13.56% -0.51	-0.59	-0.59	-0.52	-0.73
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

INCY

$86.64

1.40%

GMAB

$27.54

0.58%

SMMT

$25.98

9.16%

BNTX

$112.46

8.66%

INSM

$145.10

1.80%

ONC

$341.80

7.24%

Apri su Yahoo | Apri su Google | Aperto in Finviz | Apri in MarketWatch | Aperto a EDGAR | Aperto su Reuters